Literature DB >> 16395716

Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation.

Yan Xue1, Feng Bi, Xueyong Zhang, Siyuan Zhang, Yanglin Pan, Na Liu, Yongquan Shi, Xuebiao Yao, Yi Zheng, Daiming Fan.   

Abstract

Low oxygen tension can influence tumor progression by enhancing angiogenesis, a process that may involve Rho GTPases whose activities have been implicated in tumorigenesis and metastasis. In the present study, we show that hypoxia can increase the mRNA levels and intracellular activities of Rac1 and Cdc42 in a time-dependent manner. The hypoxia-stimulated activities of Rac1 and Cdc42 could be blocked by the phosphatidylinositol 3'-kinase (PI3K) inhibitor LY294002 and the protein tyrosine kinase (PTK) inhibitor genistein but were not affected by the p38MAPK inhibitor SB203580 or the MEK-1 inhibitor PD98059, suggesting that the hypoxia-mediated signals were through PI3K and PTK. Correlating with the increased activities of Rac1 and Cdc42, the expression of the pro-angiogenesis factors HIF-1alpha and vascular endothelial growth factor (VEGF) was upregulated by hypoxia, whereas the expression of the tumor suppressors von Hippel-Lindau and p53 was down-regulated. Dominant negative N17Rac1 and N17Cdc42 could upregulate the expression of p53 and pVHL but downregulate that of HIF-1alpha and VEGF under hypoxia. Furthermore, the preconditioned medium from N17Rac1 or N17Cdc42-expressing gastric cancer cells was able to inhibit the proliferation of HUVECs. Our results indicate that PI3K and PTK-mediated activations of Rac1 and Cdc42 are involved in the hypoxia-induced production of angiogenesis-promoting factors and tumor suppressors, and suggest that the Rho family GTPases Rac1 and Cdc42 may contribute to the hypoxia-mediated angiogenesis. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395716     DOI: 10.1002/ijc.21763

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.

Authors:  Deokbum Park; Youngmi Kim; Hyunah Kim; Kyungjong Kim; Yun-Sil Lee; Jongseon Choe; Jang-Hee Hahn; Hansoo Lee; Jongwook Jeon; Chulhee Choi; Young-Myeong Kim; Dooil Jeoung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

2.  Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo.

Authors:  Ji Ma; Jian Zhang; Yuguang Ma; Jin Zheng; Yuanxiong Cheng; Yan Xue; Wenchao Liu
Journal:  Med Oncol       Date:  2010-12-16       Impact factor: 3.064

3.  Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia.

Authors:  Xia Ke; Yanke Chen; Pei Wang; Jinliang Xing; Zhinan Chen
Journal:  Hepatol Int       Date:  2014-05-03       Impact factor: 6.047

Review 4.  PI3K/PTEN signaling in angiogenesis and tumorigenesis.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

5.  Rac1 repression reverses chemoresistance by targeting tumor metabolism.

Authors:  Shanmugasundaram Ganapathy-Kanniappan
Journal:  Cancer Biol Ther       Date:  2020-08-31       Impact factor: 4.742

6.  EGFR isoforms and gene regulation in human endometrial cancer cells.

Authors:  Lina Albitar; Gavin Pickett; Marilee Morgan; Jason A Wilken; Nita J Maihle; Kimberly K Leslie
Journal:  Mol Cancer       Date:  2010-06-25       Impact factor: 27.401

7.  RhoC is essential for the metastasis of gastric cancer.

Authors:  Na Liu; Guoyun Zhang; Feng Bi; Yanglin Pan; Yan Xue; Yongquan Shi; Liping Yao; Lina Zhao; Yi Zheng; Daiming Fan
Journal:  J Mol Med (Berl)       Date:  2007-06-05       Impact factor: 4.599

8.  Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts.

Authors:  Daniel M Appledorn; Kim-Hien T Dao; Sandra O'Reilly; Veronica M Maher; J Justin McCormick
Journal:  BMC Cancer       Date:  2010-01-12       Impact factor: 4.430

9.  RhoB is regulated by hypoxia and modulates metastasis in breast cancer.

Authors:  Julia A Ju; Inês Godet; Josh W DiGiacomo; Daniele M Gilkes
Journal:  Cancer Rep (Hoboken)       Date:  2019-02-11

Review 10.  Rho GTPases modulate malignant transformation of tumor cells.

Authors:  Jose L Orgaz; Cecilia Herraiz; Victoria Sanz-Moreno
Journal:  Small GTPases       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.